NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.020
-0.120 (-5.61%)
Jul 6, 2026, 10:14 AM EDT - Market open
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $233.61 million as of July 6, 2026. Its market cap has increased by 22.78% in one year.
Market Cap
233.61M
Enterprise Value
39.71M
1-Year Change
22.78%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $233.61M, an increase of 69.22%. That is a compound annual growth rate of 8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 233.61M | -49.09% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 263.32M |
| Fulcrum Therapeutics | 255.87M |
| Anavex Life Sciences | 255.77M |
| ProQR Therapeutics | 255.43M |
| Orchestra BioMed Holdings | 250.90M |
| AC Immune | 248.99M |
| Sol-Gel Technologies | 241.94M |
| Minerva Neurosciences | 237.60M |